Back to rankings

Aflac Inc (AFL)

Fair Value
Financial ServicesInsurance - LifeUnited States

Fundamental

60

Price

$111.78

Market Cap

$56.93B

Part 1 · What the company is worth

Overview

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on September 17, 2026 with claude-haiku-4-5 — shared with all users

P/E: 20.4Score: 58Market cap: $14.42B

Through its Colonial Life brand, Unum sells accident, hospital indemnity, cancer and critical illness policies to employees at the workplace in the United States, the same worksite voluntary-benefits business that is Aflac U.S.

P/E: 18.0Score: 58Market cap: $60.89B

Its Group Benefits arm offers accident, critical illness and hospital indemnity cover to U.S. employers through the same brokers Aflac relies on, and it is also one of the foreign insurers selling health protection products in Japan.

P/E: 11.0Score: 80Market cap: $12.81B

Its Family Heritage and Liberty National divisions sell limited-benefit supplemental health cover, including cancer and critical illness, to middle-income American families and small-business employees.

Dai-ichi Life Holdings, Inc. (第一生命ホールディングス株式会社)Not tracked

One of Japan's largest life insurers, it sells medical and cancer cover — the "third sector" products from which Aflac draws most of its profits — to Japanese households through its own agents, bank branches and its Neo First Life arm.

Tokio Marine Holdings, Inc. (東京海上ホールディングス株式会社)Not tracked

Its life subsidiary, Tokio Marine & Nichido Life, specialises in "living protection" — medical and cancer policies for Japanese individuals — competing directly with Aflac Japan's core line.

StanCorp Financial Group, Inc. (The Standard)Not tracked

After buying Allstate's Employer Voluntary Benefits business in April 2025, this insurer distributes supplemental accident, illness and life cover to millions of U.S. employees through workplace brokers.

Balance Sheet & Liquidity

Revenue

$18.07B

Trailing 12 months (through 6/30/2026)

Net Income

$4.86B

Trailing 12 months (through 6/30/2026)

Free Cash Flow

-

Total Equity

$29.49B

Total Liabilities

$86.98B

Current Ratio

0.04

Interest Coverage

-

Debt/EBITDA

2.67

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

InsuranceFairly Valued

Fair Value

$144.00

Current Price

$111.78

Margin of Safety

+22.4%

Fair Value Range

$107.59 - $180.41

Spread across the valuation methods used, not a statistically calibrated confidence interval.

Estimation Methods

Analyst price target:$118.53
Discounted cash flow (DCF):Not applicable to this type of company
Earnings multiple (P/E):$143.73
Graham growth formula:Not applicable to this type of company
Earnings power value (EPV):Not applicable to this type of company
Justified P/B:$176.53
Dividend discount (Gordon):$58.29
P/FFO, funds from operations:Not applicable to this type of company
Mid-cycle earnings:Not applicable to this type of company
Revenue multiple:Not applicable to this type of company
Analyst Consensus:Hold (3B / 12H / 9S)
Last Earnings Surprise:-1.98%

Valuation Metrics

P/E Ratio

12.06

ROE

12.4%

P/B Ratio

1.85

P/FCF

-

Gross Margin

-

ROIC

-

Profitability Radar

Value Creation (Economic Moat)

ROIC

-

WACC

6.5%

ROIC − WACC

-

Fundamental Analysis Criteria

Passed (12)

  • EPS shows upward trend
  • Price CAGR 12.73%
  • P/B Ratio 1.85
  • Debt/Equity ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Price below Graham Number
  • ROE 16.4%
  • Earnings Surprise avg 6.1%
  • Share Dilution -5.4%
  • Net Margin Trend 26.9% vs 15.3%

Failed (7)

  • EPS CAGR 4.10%
  • DCF valuation (Unknown)
  • Revenue Growth 5Y -5.0%
  • Analyst Consensus 13% Buy
  • PEG Ratio 27.31
  • Earnings Quality (OCF/NI) 0.54
  • Piotroski F-Score 4/9

Unavailable (9)

  • ROIC NaN%
  • Gross Margin NaN%
  • P/FCF NaN
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage

Piotroski F-Score

4/9

Mixed signals: some areas need attention

score
criteria

Earnings Quality

0.54

Moderate: some gap between profits and cash

Share Dilution

-5.4%

Buying back shares. Shareholder friendly

Institutional Holdings

Governance

Executive Team

NameTitleAge
Mr. Daniel Paul AmosChairman & CEO73
Mr. Virgil Raynard MillerPresident56
Mr. Max Kristian Broden C.F.A.Senior EVP & CFO46
Mr. Bradley Eugene Dyslin C.F.A.Executive VP & Global Chief Investment Officer59
Ms. Audrey Boone Tillman Esq.Senior EVP, & General Counsel60
Ms. Robin Littrell Blackmon CPA, CGMASenior VP of Financial Services & Chief Accounting Officer61
Mr. David A. YoungVice President of Capital Markets-
Mr. Bradley L. KnoxSenior VP & Counsel of Federal Relations-
Mr. Steven Kent BeaverExecutive Vice President; Chief Financial Officer, Aflac Life Insurance Japan60
Mr. Timothy L. Callahan CISM, CISSP, CRISCSenior VP & Chief Information Security Officer-

Audit Risk

8

Board Risk

5

Compensation Risk

6

Shareholder Rights Risk

9

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Documents

  • Annual Report (10-K)

    A yearly overview of the business, its financial results, and the risks it faces.

    Filed on 2026-02-25

    View document
  • Quarterly Report (10-Q)

    A snapshot of financial performance for the most recent three-month period.

    Filed on 2026-08-07

    View document
  • Current Report (8-K)

    An announcement of a major event, such as a leadership change or big news.

    Filed on 2026-08-06

    View document

via SEC EDGAR

Income History

via SEC EDGAR

Latest News

Recent headlines for AFL, sourced from Markets Gazette.

  • 5/21/2026NEUTRAL
    Aflac Follows Alphabet Into Japan’s Booming Yen Bond Market

    Aflac Inc. has entered Japan's burgeoning yen bond market, successfully issuing ¥65.9 billion ($415 million) across four tranches. This move positions Aflac alongside other foreign entities capitalizing on Japan's credit market, which is experiencing increased activity. The issuance is a strategic financial maneuver for Aflac, aimed at diversifying funding sources and potentially leveraging favorable borrowing conditions in the Japanese market. While the issuance itself is a financial operation, its direct impact on Aflac's stock price is neutral, reflecting a standard corporate finance activity rather than a fundamental business development.

via Markets Gazette